tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NYXH Stock Latest News

Nyxoah Gains FDA Approval for Genio System in U.S.
Company AnnouncementsNyxoah Gains FDA Approval for Genio System in U.S.
2d ago
6K
NYXH
Nyxoah reports preliminary Q2 revenue EUR 1.3M
PremiumThe Fly
Nyxoah reports preliminary Q2 revenue EUR 1.3M
2d ago
NYXH
Nyxoah receives FDA approval for Genio system
PremiumThe Fly
Nyxoah receives FDA approval for Genio system
5d ago
NYXH
Nyxoah’s DREAM Study Data Published, Highlighting Genio® System’s Efficacy
PremiumCompany Announcements
Nyxoah’s DREAM Study Data Published, Highlighting Genio® System’s Efficacy
15d ago
6K
NYXH
Nyxoah publishes DREAM study data in Journal of Clinical Sleep Medicine
PremiumThe Fly
Nyxoah publishes DREAM study data in Journal of Clinical Sleep Medicine
16d ago
NYXH
Nyxoah’s Innovative Approach to Sleep Apnea: A Clinical Study Update
PremiumCompany AnnouncementsNyxoah’s Innovative Approach to Sleep Apnea: A Clinical Study Update
26d ago
NYXH
Nyxoah SA Announces New Share Issuance to Strengthen Financial Structure
Premium
Company Announcements
Nyxoah SA Announces New Share Issuance to Strengthen Financial Structure
2M ago
6K
NYXH
Nyxoah Announces Change in Shareholder Voting Rights
Premium
Company Announcements
Nyxoah Announces Change in Shareholder Voting Rights
2M ago
6K
NYXH
Nyxoah SA Updates Share Capital and Voting Rights
PremiumCompany Announcements
Nyxoah SA Updates Share Capital and Voting Rights
3M ago
6K
NYXH
Nyxoah Sa’s Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Nyxoah Sa’s Earnings Call: Progress Amid Challenges
3M ago
NYXH
Nyxoah Reports Q1 2025 Financial Results and FDA Progress
PremiumCompany Announcements
Nyxoah Reports Q1 2025 Financial Results and FDA Progress
3M ago
NYXH
Nyxoah Nears FDA Approval for Genio® System Amid Q1 2025 Results
PremiumCompany Announcements
Nyxoah Nears FDA Approval for Genio® System Amid Q1 2025 Results
3M ago
6K
NYXH
Nyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year
PremiumThe FlyNyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year
3M ago
NYXH
Nyxoah Announces Changes in Shareholding by FMR LLC
Premium
Company Announcements
Nyxoah Announces Changes in Shareholding by FMR LLC
3M ago
6K
NYXH
Nyxoah SA Schedules Shareholders’ Meetings for June 2025
Premium
Company Announcements
Nyxoah SA Schedules Shareholders’ Meetings for June 2025
3M ago
6K
NYXH
Nyxoah price target lowered to $14 from $15 at Stifel
PremiumThe Fly
Nyxoah price target lowered to $14 from $15 at Stifel
4M ago
INSP
NYXH
Nyxoah Announces Conditional Issuance of 5 Million Shares
PremiumCompany Announcements
Nyxoah Announces Conditional Issuance of 5 Million Shares
4M ago
6K
NYXH
Nyxoah’s Promising Market Outlook and FDA Progress Drive Buy Rating
PremiumRatings
Nyxoah’s Promising Market Outlook and FDA Progress Drive Buy Rating
4M ago
NYXH
Nyxoah Nears FDA Approval for Genio System
PremiumCompany Announcements
Nyxoah Nears FDA Approval for Genio System
4M ago
6K
NYXH
Nyxoah anticipates FDA approval for Genio system in Q2
PremiumThe FlyNyxoah anticipates FDA approval for Genio system in Q2
4M ago
NYXH
Nyxoah price target lowered to $15 from $17 at H.C. Wainwright
Premium
The Fly
Nyxoah price target lowered to $15 from $17 at H.C. Wainwright
5M ago
NYXH
Nyxoah’s Strategic Positioning and Growth Potential in the Obstructive Sleep Apnea Market
Premium
Ratings
Nyxoah’s Strategic Positioning and Growth Potential in the Obstructive Sleep Apnea Market
5M ago
NYXH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >